Today's Change
+0.85%
AI Sentiment
61%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with bullish sentiment across 13 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $BCTXZ | BriaCell Therapeutics Corp. Warrant | -13.56% |
| $RVMDW | Revolution Medicines, Inc. Warrant | +4.86% |
| $TMCWW | TMC the metals company Inc Warrants | +60.68% |
| $CINGW | Cingulate Inc. Warrants | -10.38% |
| $ENGNW | enGene Holdings Inc. Warrants | +11.50% |
| $SDSTW | Stardust Power Inc. | -2.69% |
| $SCLXW | Scilex Holding Company | -6.43% |
| $SBFMW | Sunshine Biopharma Inc. Warrant | +0.00% |
| $NAMSW | NewAmsterdam Pharma Company N.V. Warrant | +21.31% |
| $ERNAW | Ernexa Therapeutics Inc. Warrants | +63.87% |
| $KTTAW | Pasithea Therapeutics Corp. Warrant | -1.23% |
| $TVGNW | Tevogen Bio Holdings Inc. | +12.66% |
| $CDIOW | Cardio Diagnostics Holdings Inc | -11.72% |
| $DRMAW | Dermata Therapeutics Inc - Warrants (13/08/2026) | -8.87% |
| $JSPRW | Jasper Therapeutics Inc | -15.64% |
Materials News
807 articlesGlobeNewswire Inc.14d ago
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
GlobeNewswire Inc.14d ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Coty Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – COTY
GlobeNewswire Inc.14d ago
IBRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ImmunityBio, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
GlobeNewswire Inc.15d ago
ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire Inc.15d ago
Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer
GlobeNewswire Inc.15d ago
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
GlobeNewswire Inc.15d ago
SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Hyperphagia Drug Launch Disruptions – Hagens Berman
GlobeNewswire Inc.15d ago
Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
GlobeNewswire Inc.15d ago
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
Market Sentiment
Bullish
61% Sentiment Score
Sector Stats
Total Stocks198
News Today13
Avg Volume1.3M
AI SentimentBullish